Avicenna.ai Lands Series A Funding

Avicenna.AI, a medical imaging AI specialist, has secured a Series A funding round, bringing the company’s total investment to nearly $10 million. The new funds will be used to scale up deployment of Avicenna.AI’s solutions across the world and to diversify the company’s offering into new areas of medicine. The company’s CEO Cyril Di Grandi noted the success of the company in the past year, and the plans to extend their portfolio and consolidate their position as a leader in the field with a disruptive approach to the use of deep learning in therapy.